Skip to main content

Advertisement

SpringerLink
Log in

Sulfonamide Hypersensitivity

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Sulfonamides, particularly antimicrobial sulfonamides, have been implicated as a common cause of a spectrum of hypersensitivity reactions. Immediate IgE-mediated reactions have been reported but are much less common than delayed cutaneous reactions. Delayed cutaneous reactions range from benign exanthems to severe cutaneous reactions such as Stevens Johnson syndrome, toxic epidermal necrolysis, or drug reaction with eosinophilia and systemic symptoms. Sulfonamides can be subclassified as antimicrobial sulfonamides and non-antimicrobial sulfonamides, which are also distinguished by key structural differences, resulting in very low risk of cross-reactivity between these two subclasses. Immediate and delayed skin testing and in vitro testing remain limited as options in evaluating antimicrobial sulfonamide hypersensitivity. Drug challenges continue to play an important role in the evaluation of both immediate and delayed reactions, with a growing body of evidence for the safety of direct challenges regardless of human immunodeficiency virus infection status. While numerous “desensitization” protocols have been described for the management of antimicrobial sulfonamide hypersensitivity, there is limited evidence that such procedures are successful because of an induction of tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev (10):CD005590

  2. Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP, Bates DW (2016) Drug allergies documented in electronic health records of a large healthcare system. Allergy 71(9):1305–1313

    Article  CAS  PubMed  Google Scholar 

  3. Cohen LS, Cluff LE (1961) The sulfonamides. Am J Nurs 61:54–58

    Article  CAS  PubMed  Google Scholar 

  4. Domagk G (1935) Ein beitrag zur chemotherapie der bakterielen infektione. Deutsche Med Wchn 61:250–253

    Article  CAS  Google Scholar 

  5. Knowles S, Shapiro L, Shear NH (2001) Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of “sulfa” allergy. Drug Saf 24(4):239–247

    Article  CAS  PubMed  Google Scholar 

  6. Khan DA, Knowles SR, Shear NH (2019) Sulfonamide hypersensitivity: fact and fiction. J Allergy Clin Immunol Pract 7(7):2116–2123

    Article  PubMed  Google Scholar 

  7. Brackett CC, Singh H, Block JH (2004) Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 24(7):856–870

    Article  CAS  PubMed  Google Scholar 

  8. Harle DG, Baldo BA, Wells JV (1988) Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole. Mol Immunol 25(12):1347–1354

    Article  CAS  PubMed  Google Scholar 

  9. Carrington DM, Earl HS, Sullivan TJ (1987) Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 79(3):442–447

    Article  CAS  PubMed  Google Scholar 

  10. Platt R, Dreis MW, Kennedy DL, Kuritsky JN (1988) Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. J Infect Dis 158(2):474–477

    Article  CAS  PubMed  Google Scholar 

  11. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH (1994) Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 84(1):176–183

    Article  CAS  PubMed  Google Scholar 

  12. Han T, Chawla PL, Sokal JE (1969) Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. N Engl J Med 280(10):547–548

    Article  CAS  PubMed  Google Scholar 

  13. Ermis B, Caner I, Karacan M, Olgun H (2003) Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use. Thromb Haemost 90(1):158–159

    PubMed  Google Scholar 

  14. Watkins S, Pichler W (2013) Activating interactions of sulfanilamides with T cell receptors. Open Journal of Immunology 3:139–157

    Article  CAS  Google Scholar 

  15. Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, Naisbitt DJ (2010) Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol 125(2):411–418 e414

  16. Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, Pichler WJ (2000) Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164(12):6647–6654

    Article  CAS  PubMed  Google Scholar 

  17. Lehmann DF (2012) The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs. Drug Metab Lett 6(2):129–133

    Article  CAS  PubMed  Google Scholar 

  18. Ladero JM (2008) Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs. Curr Drug Metab 9(6):532–537

    Article  CAS  PubMed  Google Scholar 

  19. Cribb AE, Spielberg SP (1992) Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 51(5):522–526

    Article  CAS  PubMed  Google Scholar 

  20. Cribb AE, Spielberg SP, Griffin GP (1995) N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 23(3):406–414

    CAS  PubMed  Google Scholar 

  21. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W (1986) Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105(2):179–184

    Article  CAS  PubMed  Google Scholar 

  22. Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP (1991) Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab Dispos 19(5):900–906

  23. Elzagallaai AA, Sultan EA, Bend JR, Abuzgaia AM, Loubani E, Rieder MJ (2020) Role of oxidative stress in hypersensitivity reactions to sulfonamides. J Clin Pharmacol 60(3):409–421

    Article  CAS  PubMed  Google Scholar 

  24. Arp J, Rieder MJ, Urquhart B, Freeman D, Tucker MJ, Krizova A, Lehmann D, Dekaban GA (2005) Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat. J Pharmacol Exp Ther 314(3):1218–1225

    Article  CAS  PubMed  Google Scholar 

  25. Akerlund B, Tynell E, Bratt G, Bielenstein M, Lidman C (1997) N-acetylcysteine treatment and the risk of toxic reactions to trimethoprim-sulphamethoxazole in primary Pneumocystis carinii prophylaxis in HIV-infected patients. J Infect 35(2):143–147

    Article  CAS  PubMed  Google Scholar 

  26. Walmsley SL, Khorasheh S, Singer J, Djurdjev O (1998) A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 19(5):498–505

  27. Alfirevic A, Stalford AC, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M (2003) Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity. Br J Clin Pharmacol 55(2):158–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sacco JC, Abouraya M, Motsinger-Reif A, Yale SH, McCarty CA, Trepanier LA (2012) Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. Pharmacogenet Genomics 22(10):733–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Reinhart JM, Motsinger-Reif A, Dickey A, Yale S, Trepanier LA (2016) Genome-wide association study in immunocompetent patients with delayed hypersensitivity to sulfonamide antimicrobials. PLoS One 11(6):e0156000

  30. Wang D, Curtis A, Papp AC, Koletar SL, Para MF (2012) Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. BMC Med Genomics 5:32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kongpan T, Mahasirimongkol S, Konyoung P, Kanjanawart S, Chumworathayi P, Wichukchinda N, Kidkeukarun R, Preechakul S, Khunarkornsiri U, Bamrungram W et al (2015) Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Pharmacogenet Genomics 25(8):402–411

    Article  CAS  PubMed  Google Scholar 

  32. Klaewsongkram J, Sukasem C, Thantiworasit P, Suthumchai N, Rerknimitr P, Tuchinda P, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K et al (2019) Analysis of HLA-B allelic variation and IFN-γ ELISpot responses in patients with severe cutaneous adverse reactions associated with drugS. J Allergy Clin Immunol Pract 7(1):219-227.e214

    Article  PubMed  Google Scholar 

  33. Li YJ, Phillips E, Dellinger A, Nicoletti P, Schutte R, Li D, Ostrov DA, Fontana RJ, Watkins PB, Stolz A et al (2020) HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury. Hepatology

  34. Macy E, Poon KYT (2009) Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 122(8):778 e771–777

  35. McConeghy KW, Caffrey AR, Morrill HJ, Trivedi AN, LaPlante KL (2017) Are non-allergic drug reactions commonly documented as medication “allergies”? A national cohort of Veterans’ admissions from 2000 to 2014. Pharmacoepidemiol Drug Saf 26(4):472–476

    Article  CAS  PubMed  Google Scholar 

  36. Wong A, Seger DL, Lai KH, Goss FR, Blumenthal KG, Zhou L (2019) Drug hypersensitivity reactions documented in electronic health records within a large health system. J Allergy Clin Immunol Pract 7(4):1253–1260 e1253

  37. Jaffe HS, Abrams DI, Ammann AJ, Lewis BJ, Golden JA (1983) Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 2(8359):1109–1111

    Article  CAS  PubMed  Google Scholar 

  38. Gordin FM, Simon GL, Wofsy CB, Mills J (1984) Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100(4):495–499

    Article  CAS  PubMed  Google Scholar 

  39. Eliaszewicz M, Flahault A, Roujeau JC, Fillet AM, Challine D, Mansouri S, Wolkenstein P, Aractingi S, Penso-Assathiany D, Maslo C et al (2002) Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J Am Acad Dermatol 47(1):40–46

    Article  PubMed  Google Scholar 

  40. Chang HM, Tsai HC, Lee SS, Kunin C, Lin PC, Wann SR, Chen YS (2016) High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS. J Chin Med Assoc 79(6):314–319

    Article  PubMed  Google Scholar 

  41. Kato H, Samukawa S, Takahashi H, Nakajima H (2019) Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole. J Infect Chemother 25(11):920–924

    Article  CAS  PubMed  Google Scholar 

  42. Alfirevic A, Vilar FJ, Alsbou M, Jawaid A, Thomson W, Ollier WE, Bowman CE, Delrieu O, Park BK, Pirmohamed M (2009) TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole. Pharmacogenomics 10(4):531–540

    Article  CAS  PubMed  Google Scholar 

  43. Reichmann J (1960) Anaphylactic shock caused by intravenous sulfonamide application with fatal outcome. Dtsch Gesundheitsw 15:1139–1141

    CAS  PubMed  Google Scholar 

  44. Fujiwara Y, Inomata N, Ishida S, Miyakawa M, Nomura Y, Mitani N, Aihara M (2017) Contact urticaria syndrome caused by sulfamethoxazole sodium contained in eye drops. Contact Dermatitis 77(1):56–57

    Article  PubMed  Google Scholar 

  45. Bijl AM, Van der Klauw MM, Van Vliet AC, Stricker BH (1998) Anaphylactic reactions associated with trimethoprim. Clin Exp Allergy 28(4):510–512

    Article  CAS  PubMed  Google Scholar 

  46. Hansbrough JR, Wedner HJ, Chaplin DD (1987) Anaphylaxis to intravenous furosemide. J Allergy Clin Immunol 80(4):538–541

    Article  CAS  PubMed  Google Scholar 

  47. Jick H (1982) Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 4(2):426–428

    Article  CAS  PubMed  Google Scholar 

  48. Nguyen AT, Gentry CA, Furrh RZ (2013) A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting. Curr Drug Saf 8(2):114–119

    Article  CAS  PubMed  Google Scholar 

  49. Chantachaeng W, Chularojanamontri L, Kulthanan K, Jongjarearnprasert K, Dhana N (2011) Cutaneous adverse reactions to sulfonamide antibiotics. Asian Pac J Allergy Immunol 29(3):284–289

    CAS  PubMed  Google Scholar 

  50. Wright AA, Vesta KS, Stark JE, Smith WJ (2010) Stevens-Johnson syndrome associated with furosemide: a case report. J Pharm Pract 23(4):367–370

    Article  PubMed  Google Scholar 

  51. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128(1):35–44

    Article  CAS  PubMed  Google Scholar 

  52. Firoz BF, Henning JS, Zarzabal LA, Pollock BH (2012) Toxic epidermal necrolysis: five years of treatment experience from a burn unit. J Am Acad Dermatol 67(4):630–635

    Article  PubMed  Google Scholar 

  53. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071–1080

  54. Trubiano JA, Aung AK, Nguyen M, Fehily SR, Graudins L, Cleland H, Padiglione A, Peleg AY (2016) A comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions. J Allergy Clin Immunol Pract 4(6):1187–1193

    Article  PubMed  Google Scholar 

  55. Kelly JP, Kaufman DW, Dunant A, Mockenhaupt M, Roujeau JC (2011) Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole. J Am Acad Dermatol 64(6):1193–1194

    Article  PubMed  Google Scholar 

  56. Anliker MD, Wuthrich B (2003) Acute generalized exanthematous pustulosis due to sulfamethoxazol with positive lymphocyte transformation test (LTT). J Investig Allergol Clin Immunol 13(1):66–68

    PubMed  Google Scholar 

  57. Philpott OS (1947) Sulfonamide psoriasiform dermatitis. Arch Derm Syphilol 55(4):525–534

    Article  CAS  PubMed  Google Scholar 

  58. Tam CC, Ingraffea AA (2015) Sweet syndrome presenting with an unusual morphology. Cutis 96(2):E9-10

    PubMed  Google Scholar 

  59. Culav I, Ljubojevic S, Buzina DS (2013) Baboon syndrome/SDRIFE due to sulfamethoxazole-trimethoprim. Int J Dermatol 52(9):1159–1160

    Article  CAS  PubMed  Google Scholar 

  60. Esposito M, Saraceno R, Schipani C, Di Marcantonio D, Bianchi L, Chimenti S (2008) Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis. J Infect 57(1):90–92

    Article  PubMed  Google Scholar 

  61. Baltazard T, Dhaille F, Duvert-Lehembre S, Lok C, Chaby G (2017) Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Dermatol Online J 23(8)

  62. Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H et al (2015) Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148(7):1340–1352 e1347

  63. Lindgren A, Olsson R (1994) Liver reactions from trimethoprim. J Intern Med 236(3):281–284

    Article  CAS  PubMed  Google Scholar 

  64. Joint Task Force on Practice P, American Academy of Allergy A, Immunology, American College of Allergy A, Immunology, Joint Council of Allergy A, Immunology (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105(4):259–273

  65. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W et al (2014) International Consensus on drug allergy. Allergy 69(4):420–437

    Article  CAS  PubMed  Google Scholar 

  66. Gruchalla RS, Sullivan TJ (1991) Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol 88(5):784–792

    Article  CAS  PubMed  Google Scholar 

  67. Empedrad R, Darter AL, Earl HS, Gruchalla RS (2003) Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 112(3):629–630

    Article  CAS  PubMed  Google Scholar 

  68. Shapiro LE, Knowles SR, Weber E, Neuman MG, Shear NH (2003) Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Drug Saf 26(3):187–195

    Article  CAS  PubMed  Google Scholar 

  69. Gompels MM, Simpson N, Snow M, Spickett G, Ong E (1999) Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? J Infect 38(2):111–115

    Article  CAS  PubMed  Google Scholar 

  70. Kardaun SH, de Waard MM, de Monchy JG (2009) Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization. Contact Dermatitis 61(1):50–51

    Article  CAS  PubMed  Google Scholar 

  71. Lee AY (1998) Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 38(5):258–260

    Article  CAS  PubMed  Google Scholar 

  72. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G (1999) Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis 41(4):185–189

    Article  CAS  PubMed  Google Scholar 

  73. Tornero P, De Barrio M, Baeza ML, Herrero T (2004) Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing. Contact Dermatitis 51(2):57–62

    Article  CAS  PubMed  Google Scholar 

  74. Moreno Escobosa MC, Cruz Granados S, Moya Quesada MC, Amat Lopez J (2009) Enanthema and fixed drug eruption caused by trimethoprim. J Investig Allergol Clin Immunol 19(3):249–250

    CAS  PubMed  Google Scholar 

  75. Klein CE, Trautmann A, Zillikens D, Brocker EB (1996) Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 35(3):175–176

    Article  CAS  PubMed  Google Scholar 

  76. Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, Vultaggio A, Brockow K, Caubet JC, Makowska J et al (2016) In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71(8):1103–1134

    Article  CAS  PubMed  Google Scholar 

  77. Broyles AD, Banerji A, Castells M (2020) Practical guidance for the evaluation and management of drug hypersensitivity: general concepts. J Allergy Clin Immunol Pract 8(9S):S3–S15

    Article  PubMed  Google Scholar 

  78. Kalish RS, LaPorte A, Wood JA, Johnson KL (1994) Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 94(3 Pt 1):465–472

    Article  CAS  PubMed  Google Scholar 

  79. Jung M, Kim J, Lee JY, Kim M, Kim SH, Ahn K (2019) Trimethoprim-sulfamethoxazole induces acute pancreatitis associated with drug-specific cytotoxic T lymphocytes. J Allergy Clin Immunol Pract 7(1):336–338

    Article  PubMed  Google Scholar 

  80. Monge-Ortega OP, Cabanas R, Fiandor A, Dominguez-Ortega J, Gonzalez-Munoz M, Quirce S, Lluch-Bernal M, Bellon T (2018) Overlap Between DRESS syndrome and exanthema induced by sulfadiazine in a patient treated with sulfamethoxazole: utility of the lymphocyte transformation test for identification of the culprit drug. J Investig Allergol Clin Immunol 28(2):132–134

    Article  CAS  PubMed  Google Scholar 

  81. Reinhart JM, Rose W, Panyard DJ, Newton MA, Liebenstein TK, Yee J, Trepanier LA (2018) RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes. Pharmacol Res Perspect 6(2):e00388

  82. Leoung GS, Stanford JF, Giordano MF, Stein A, Torres RA, Giffen CA, Wesley M, Sarracco T, Cooper EC, Dratter V et al (2001) Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. J Infect Dis 184(8):992–997

    Article  CAS  PubMed  Google Scholar 

  83. Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cagni AE, Franzetti M, Faggion I, Landonio S, Quirino T (2000) The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group. Biomed Pharmacother 54(1):45–49

  84. Krantz MS, Stone CA, Jr., Abreo A, Phillips EJ (2020) Oral challenge with trimethoprim-sulfamethoxazole in patients with "sulfa" antibiotic allergy. J Allergy Clin Immunol Pract 8(2):757–760 e754.

  85. Urbancic KF, Ierino F, Phillips E, Mount PF, Mahony A, Trubiano JA (2018) Taking the challenge: a protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. Am J Transplant 18(2):462–466

    Article  CAS  PubMed  Google Scholar 

  86. Grinlington L, Choo S, Cranswick N, Gwee A (2020) Non-β-lactam antibiotic hypersensitivity reactions. Pediatrics 145(1)

  87. Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL (2006) Is there cross-reactivity between penicillins and cephalosporins? Am J Med 119(4):354 e311–359

  88. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D (2003) Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 349(17):1628–1635

    Article  CAS  PubMed  Google Scholar 

  89. Buijs BS, van den Berk GE, Boateng CP, Hoepelman AI, van Maarseveen EM, Arends JE (2015) Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS 29(7):785–791

    Article  CAS  PubMed  Google Scholar 

  90. Prezista (Darunavir) (2011) [package insert]. Titusville, NJ: Janssen Pharmaceuticals

  91. May SM, Motosue MS, Park MA (2017) Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance. J Allergy Clin Immunol Pract 5(3):831–833

    Article  PubMed  Google Scholar 

  92. Holtzer CD, Flaherty JF Jr, Coleman RL (1998) Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Pharmacotherapy 18(4):831–835

    CAS  PubMed  Google Scholar 

  93. Beumont MG, Graziani A, Ubel PA, MacGregor RR (1996) Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. Am J Med 100(6):611–616

    Article  CAS  PubMed  Google Scholar 

  94. Ghimire S, Kyung E, Lee JH, Kim JW, Kang W, Kim E (2013) An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. J Clin Pharm Ther 38(3):196–202

    Article  CAS  PubMed  Google Scholar 

  95. Wulf NR, Matuszewski KA (2013) Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Health Syst Pharm 70(17):1483–1494

    Article  CAS  PubMed  Google Scholar 

  96. Dorn JM, Alpern M, McNulty C, Volcheck GW (2018) Sulfonamide drug allergy. Curr Allergy Asthma Rep 18(7):38

    Article  PubMed  Google Scholar 

  97. Scherer K, Brockow K, Aberer W, Gooi JH, Demoly P, Romano A, Schnyder B, Whitaker P, Cernadas JS, Bircher AJ et al (2013) Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group. Allergy 68(7):844–852

    Article  CAS  PubMed  Google Scholar 

  98. Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN et al (2020) Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract 8(9S):S16–S116

    Article  PubMed  Google Scholar 

  99. Lin D, Li WK, Rieder MJ (2007) Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Cochrane Database Syst Rev (2):CD005646

  100. Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, Andre P, Reynes J, Godard P, Bousquet J (1998) Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol 102(6 Pt 1):1033–1036

    Article  CAS  PubMed  Google Scholar 

  101. Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, Harish A, Poe KL, Park MA (2014) Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. J Allergy Clin Immunol Pract 2(1):52–58

    Article  PubMed  Google Scholar 

  102. Gluckstein D, Ruskin J (1995) Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis 20(4):849–853

    Article  CAS  PubMed  Google Scholar 

  103. Patriarca G, Schiavino D, Buonomo A, Aruanno A, Altomonte G, Nucera E (2008) Desensitization to co-trimoxazole in a patient with fixed drug eruption. J Investig Allergol Clin Immunol 18(4):309–311

    CAS  PubMed  Google Scholar 

  104. Douglas R, Spelman D, Czarny D, O’Hehir RE (1997) Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole. Clin Infect Dis 25(6):1480

    Article  CAS  PubMed  Google Scholar 

  105. Straatmann A, Bahia F, Pedral-Sampaio D, Brites C (2002) A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides. Braz J Infect Dis 6(6):276–280

    Article  PubMed  Google Scholar 

  106. Putterman C, Rahav G, Shalit M, Rubinow A (1990) “Treating through” hypersensitivity to co-trimoxazole in AIDS patients. Lancet 336(8706):52

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Timothy G Chow & David A Khan

Authors
  1. Timothy G Chow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David A Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy G Chow.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chow, T.G., Khan, D.A. Sulfonamide Hypersensitivity. Clinic Rev Allerg Immunol 62, 400–412 (2022). https://doi.org/10.1007/s12016-021-08872-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-021-08872-3

Keywords

Search

Navigation